Pages that link to "Q55274460"
Jump to navigation
Jump to search
The following pages link to Nanocomplex-based TP53 gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanisms. (Q55274460):
Displaying 6 items.
- Combination with SGT-53 overcomes tumor resistance to a checkpoint inhibitor (Q57137831) (← links)
- Crosstalk Between PD-1/PD-L1 Blockade and Its Combinatorial Therapies in Tumor Immune Microenvironment: A Focus on HNSCC (Q59813521) (← links)
- Gene Therapy in Cancer Treatment: Why Go Nano? (Q90163228) (← links)
- Identification and Validation of Tumor Stromal Immunotype in Patients With Hepatocellular Carcinoma (Q92859983) (← links)
- A tumor-targeting nanomedicine carrying the p53 gene crosses the blood-brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma (Q93038215) (← links)
- Detection of immunogenic cell death and its relevance for cancer therapy (Q103001166) (← links)